Sun Pharmaceuticals Industries (NSE:SUNPHARMA) 3-Year EBITDA Growth Rate : 18.10% (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Sun Pharmaceuticals Industries 3-Year EBITDA Growth Rate?

Sun Pharmaceuticals Industries's EBITDA per Share for the three months ended in Dec. 2023 was ₹15.22.

During the past 12 months, Sun Pharmaceuticals Industries's average EBITDA Per Share Growth Rate was 75.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 18.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 11.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 2.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sun Pharmaceuticals Industries was 50.30% per year. The lowest was -11.70% per year. And the median was 18.60% per year.

Competitive Comparison of Sun Pharmaceuticals Industries's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sun Pharmaceuticals Industries's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's 3-Year EBITDA Growth Rate falls into.

Sun Pharmaceuticals Industries 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sun Pharmaceuticals Industries 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

524715:India

Address

Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063

Website

https://www.sunpharma.com

Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Headlines

No Headlines